NAVERIS INC.

In News

CareDx to Acquire Oncology Diagnostics Company Naveris for $160 Million - Clinical Lab Products

Clinical Lab Products - Apr 29, 2026

CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing - Business Wire

Business Wire - Apr 28, 2026

CareDx Acquires Naveris, Extends Leadership into High-Growth Specialty Oncology - Yahoo Finance

Yahoo Finance - Jul 02, 2026

This company is letting a virus guide its new focus on cancer testing - The Business Journals

The Business Journals - Jul 22, 2026

CareDx completes acquisition of Naveris - Investing.com

Investing.com - Jul 01, 2026

CareDx’s Growth Prospects With Naveris Keep Me Bullish (NASDAQ:CDNA) - Seeking Alpha

Seeking Alpha - Jul 20, 2026

CDNA: Q1 revenue up 39%, pipeline expands with Naveris and AlloHeme, driving future growth - TradingView

TradingView - Jun 03, 2026

CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology - Business Wire

Business Wire - Jul 01, 2026

CareDx Completes Naveris Acquisition and Expands Oncology Reach - Yahoo Finance

Yahoo Finance - Jul 07, 2026

CareDx (CDNA) Jumps As Naveris Deal Redraws Growth Map - timothysykes.com

timothysykes.com - Jul 16, 2026

CareDx to Acquire Naveris to Expand Into Cancer MRD Testing - Yahoo Finance

Yahoo Finance - Apr 28, 2026

Naveris® to Highlight New Publications at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire

Business Wire - Jan 09, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment